Ticker: MAIA

Quick take - MAIA Biotechnology, Inc. (NYSEMKT: MAIA) MAIA is a clinical‑stage oncology company advancing its lead telomere‑targeting drug ateganosine (THIO). The quarter shows active clinical progress and partnerships (Regeneron, BeiGene, Roche) and ongoing fundraises, but the business still pos...